2 completed, 1 not yet recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow arotinolol: new trials by email Literature Review of arotinolol trials Research Report on arotinolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension Antihypertensive treatment with Arotinolol or Amlodipine or Clonidine, Placebo-controlled group - Chronic Kidney Disease(CKD), Nocturnal Hypertension | Not applicable | Not yet recruiting | Shanghai Institute of Hypertension | 200 | 2025-01-30 | 2025-01-17 |
| Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate Arotinolol Hydrochloride, Metoprolol succinate sustained-release tablet - Essential Hypertension | Phase 4 | Completed | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 198 | 2015-08-01 | 2019-04-17 |
| Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients Arotinolol Hydrochloride, Non arotinolol group - Chronic Kidney Disease | Phase 4 | Completed | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 300 | 2011-04-01 | 2019-04-17 |
Renal Insufficiency, Chronic (2) · Essential Hypertension (1) · Hypertension (1)
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. (2) · Shanghai Institute of Hypertension (1)
China (2)
Nan Chen, PhD, MD (1) · Yundai Chen, MD (1)